Patient Empowerment for Major Surgery Preparation @ Home
NCT ID: NCT05167682
Last Updated: 2024-06-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
26 participants
OBSERVATIONAL
2021-07-01
2024-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
After determination of the oncologic treatment plan in the tumor board and functional assessment, patient will undergo an interdisciplinary assessment , which will be performed by the PAPRIKA team consisting of physiotherapists, internists/geriatricians, speech and occupational therapists, nutritionists and surgeons.
On the basis of this interdisciplinary assessment an individualized catalog of procedures will be created. Patient have to follow to this catalog of procedures until surgery. Procedures catalog contains behavioral changes, physical training, nutritional counseling, conditioning of pulmonary function and optimization of drug treatment of underlying diseases.
The individual treatments will be weekly reevaluated and if necessary the procedures will be adjusted by treatment teams.
The prehabilitation procedures will be communicated with the patient via a smartphone app, which is specially developed for the prehabilitation program. The implementation will be documented.
The primary aim of this study is to evaluate the compliance of the patients regarding to the prescribed procedures and the use of the smartphone app (feasibility).
As secondary aim postoperative outcome will be compared with the results of a historical cohort for quality control.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PAPRIKA - Patients Empowerment for Major Surgery Preparation @Home
NCT04295668
Multimodal Prehabilitation in Cancer Surgery
NCT06788834
PROMs-guided Perioperative Care in Patients With Complex Care Needs: An Open-label Randomized Controlled Trial
NCT07338188
PROMIS and Mobility Evaluation in Sarcoma Patients
NCT07227961
The Effectiveness of Telemedicine Monitoring Prehabilitation in Prostate Cancer Patients Undergoing Radical Prostatectomy
NCT06981026
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prehabilitation
25 patients scheduled for tumor-esophagectomy (Ivor-Lewis) who are capable and have given consent to participate in a smartphone-based prehabilitation program.
Prehabilitation program
Patient will be asked to follow to catalog of procedures till surgery. Procedures catalog contains behavioral changes, physical training, nutritional counseling, conditioning of pulmonary function and optimization of drug of underlying diseases.
Historical Cohort
Patients ≥ 65 years of age who have undergone tumor-related esophagectomy at the University Hospital of Cologne between 05/2016 and 04/2020, who have not participated in any form of prehabilitation procedures
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prehabilitation program
Patient will be asked to follow to catalog of procedures till surgery. Procedures catalog contains behavioral changes, physical training, nutritional counseling, conditioning of pulmonary function and optimization of drug of underlying diseases.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \>65 years
* American Society of Anaesthesiologists - Score: 2-3
* Ability to give informed consent
* Written informed consent
Exclusion Criteria
* Urgent surgery indication
* Patients with good to excellent general and nutritional condition (0 points in the pre-screening of the modified NRS OR 1 point in the pre-screening and \<2 points in the main screening).
* Patients deemed by the PAPRIKA team to be physically or mentally incapable of completing the exercise program.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Department of General, Visceral, Tumor and Transplant Surgery, University Hospital Of Cologne
UNKNOWN
Centre for Prevention and Rehabilitation, University Hospital Cologne
UNKNOWN
Department of Endocrinology, Diabetology and Preventive Medicine
UNKNOWN
University of Cologne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Paul Brinkkoetter
Prof. MD, Consultant in Nephrology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wolfgang Schröder, Prof.
Role: STUDY_CHAIR
Department of General, Visceral and Transplantational Surgery, University Hospital of Cologne
Paul Brinkkötter, Prof.
Role: PRINCIPAL_INVESTIGATOR
Department of Internal Medicine II, University Hospital of Cologne
Linus Völker, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Internal Medicine II, University Hospital of Cologne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Cologne
Cologne, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
V02-20012021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.